Ace the Oncology Nursing Game: 2026 Chemo-Bio Certification Practice Test Adventure!

The discovery of the first alkylating agent is attributed to Paul Ehrlich, who was a pioneering scientist in the field of chemotherapy and pharmacology. Alkylating agents, which are a class of chemotherapy drugs, work by adding an alkyl group to the DNA molecule. This process inhibits cell division and promotes cell death, particularly in rapidly dividing cancer cells. Ehrlich's work laid the foundation for developing targeted therapies and expanding the understanding of how chemical agents can interact with cancer cell biology. His insights into the mechanisms of action of various compounds helped to shape modern oncology practices. This legacy continues to influence current cancer treatment strategies and research into new therapeutic agents.